Company Filing History:
Years Active: 2021-2024
Title: Innovator Spotlight: Michael Brent Shelton - Pioneering Cardiac Therapies
Introduction: Michael Brent Shelton, based in Golden Valley, MN, is a distinguished inventor recognized for his contributions to the field of cardiac therapy. With a focus on developing advanced technologies for treating atrial arrhythmias, Shelton has been awarded two patents that showcase his innovative approach to medical device design.
Latest Patents: One of Shelton's latest patents involves a groundbreaking device known as multi-stage atrial cardioversion therapy leads. This invention includes a single-pass lead designed for optimal positioning within or adjacent to the right atrium of a patient's heart. The lead comprises a body portion equipped with at least two electrodes and a distal portion featuring at least two electrodes positioned within a blood vessel close to the left atrium. This invention is intended to operate in conjunction with an implantable therapy generator, programmed to deliver multi-stage therapy by activating various combinations of electrodes, thereby improving treatment efficacy for patients experiencing atrial arrhythmias.
Career Highlights: Throughout his career, Michael Brent Shelton has made significant strides in the biomedical industry. His innovative spirit and technical expertise have played a vital role in enhancing cardiac care solutions. His patents reflect a commitment to improving patient outcomes and advancing the understanding of cardiac arrhythmias.
Collaborations: Michael Brent Shelton has collaborated with notable organizations in the biomedical field, including Maxwell Biomedical Inc. and Cardialen, Inc. These partnerships have allowed him to leverage resources and expertise in developing effective therapies that address complex cardiac conditions.
Conclusion: As an inventor, Michael Brent Shelton has made remarkable contributions to the development of cardiac therapy devices. His patented technologies demonstrate a unique blend of innovation and practicality aimed at enhancing the treatment of atrial arrhythmias. With a focus on improving patient care through advanced medical technology, Shelton continues to be a valuable asset in the field of biomedical engineering.